T44.0X5 Category · further specificity required Adverse effect of anticholinesterase agents
ICD-10-CM T44.0X5 identifies “Adverse effect of anticholinesterase agents” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T44 · Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
Seventh character1
The appropriate 7th character is to be added to each code from category T44
A — initial encounter
D — subsequent encounter
S — sequela
More specific codes
Official index references
Official index references (21)
Ambenonium(chloride) (1)
- Ambenonium(chloride)Drugs and chemicals
Anticholinesterase (3)
- AnticholinesteraseDrugs and chemicals
- Anticholinesterase › organophosphorusDrugs and chemicals
- Anticholinesterase › reversibleDrugs and chemicals
Cholinergic(drug) NEC (1)
- Cholinergic(drug) NEC › organophosphorusDrugs and chemicals
DFP (1)
- DFPDrugs and chemicals
Diflos (1)
- DiflosDrugs and chemicals
Difluorophate (1)
- DifluorophateDrugs and chemicals
Diisopropylfluorophosphate (1)
- DiisopropylfluorophosphateDrugs and chemicals
Distigmine(bromide) (1)
- Distigmine(bromide)Drugs and chemicals
Dyflos (1)
- DyflosDrugs and chemicals
Edrophonium (2)
- EdrophoniumDrugs and chemicals
- Edrophonium › chlorideDrugs and chemicals
Galantamine (1)
- GalantamineDrugs and chemicals
Isoflurophate (1)
- IsoflurophateDrugs and chemicals
Neomycin(derivatives) (1)
- Neomycin(derivatives) › with › neostigmineDrugs and chemicals
Neostigmine bromide (1)
- Neostigmine bromideDrugs and chemicals
Prostigmin (1)
- ProstigminDrugs and chemicals
Pyridostigmine bromide (1)
- Pyridostigmine bromideDrugs and chemicals
Tacrine (1)
- TacrineDrugs and chemicals
Tetrahydroaminoacridine (1)
- TetrahydroaminoacridineDrugs and chemicals
History
Code history
Latest recorded change · FY2025 · 04-01
Effective from
- Inherited rules changed
Adverse effect of anticholinesterase agents
Category — select a more specific code
CDC/NCHS · FY2025 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.